European Journal of Pediatrics

, Volume 172, Issue 2, pp 171–177 | Cite as

Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines—prognosis and outcome after booster vaccination

Original Article

Abstract

Persistent itching subcutaneous nodules and aluminium (Al) allergy have been described after vaccination with Al-adsorbed vaccines but are considered rare. Little is known about the prognosis. Sixty-four children with itching nodules following vaccination with diphtheria–tetanus–pertussis (DTP) vaccines currently used in Sweden (Infanrix® and Pentavac®) were spontaneously reported to the authors from 1999 and followed for up to 12 years. The median duration of itching was 5 years in the 44 children who were free or almost free from symptoms at the latest follow-up. Typical findings were a long interval between vaccination and onset of symptoms (months or years) and intensified itching during intercurrent infections. Contact allergy to aluminium was demonstrated in 60/63 children (95 %). Neither the incidence nor differences between the two vaccines can be estimated from this study, but vaccine-induced itching nodules are probably more common than hitherto realised. The median interval between onset of symptoms and diagnosis was 8 months in a region where nurses were educated to recognise the condition compared to 2 years in other regions. Booster vaccination with DTP-polio was postponed or declined by 15/40 families in fear for new problems. Out of 25 children who received a booster dose, only two had new itching nodules. Conclusion: Intensely itching subcutaneous nodules (vaccination granulomas) and contact allergy to aluminium may occur after primary vaccination with the two most commonly used DTP vaccines in Europe. The condition is probably underreported. Symptoms may last for at least 4–5 years but eventually seem to subside.

Keywords

Itching nodule Granuloma Contact allergy Aluminium Adjuvant Vaccines 

References

  1. 1.
    Al-Suliman NN, Grabau DA, Kiaer H, Rasmussen M, Bak M (1999) A tumour in the breast: vaccination granuloma as a differential diagnosis. Eur J Surg Oncol 25:34–37PubMedCrossRefGoogle Scholar
  2. 2.
    Beck MH, Wilkinson SM (2004) Contact dermatitis: allergic contact dermatitis to specific allergens. In: Burns T, Breathnach S, Cox N, Griffiths C (eds) Rook’s textbook of dermatology, 7th edn. Blackwell Science, Oxford. Vol. 1, Chapter 20, p. 47Google Scholar
  3. 3.
    Bergfors E, Trollfors B, Inerot A (2003) Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer. Vaccine 22:64–69PubMedCrossRefGoogle Scholar
  4. 4.
    Bergfors E, Björkelund C, Trollfors B (2005) Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines. Eur J Pediatr 164:691–697PubMedCrossRefGoogle Scholar
  5. 5.
    Beveridge MG, Polcari IC, Burns JL, Adler A, Hendrickson B, Stein SL (2012) Local vaccine site reactions and contact allergy to aluminum. Pediatr Dermatol 29(1):68–72PubMedCrossRefGoogle Scholar
  6. 6.
    Bordet AL, Michenet P, Cohen C et al (2001) Post-vaccination granuloma due to aluminium hydroxide. Ann Pathol 21:149–152PubMedGoogle Scholar
  7. 7.
    Castelain PY, Castelain M, Vervloet D, Garbe L, Mallet B (1988) Sensitization to aluminium by aluminium-precipitated dust and pollen extracts. Contact Dermatitis 19(1):58–60PubMedCrossRefGoogle Scholar
  8. 8.
    Clemmensen O, Knudsen HE (1980) Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen. Contact Dermatitis 6(5):305–308PubMedCrossRefGoogle Scholar
  9. 9.
    Cosnes A, Flechet ML, Revuz J (1990) Inflammatory nodular reactions after hepatitis B vaccination due to Al sensitization. Contact Dermatitis 23:65–67PubMedCrossRefGoogle Scholar
  10. 10.
    Cox NH, Moss C, Forsyth A (1988) Cutaneous reactions to Al in vaccines: an avoidable problem. Lancet 2:43PubMedCrossRefGoogle Scholar
  11. 11.
    Croce S, Lhermitte B, Tomasetto C et al (2008) Late-onset vaccination-induced subcutaneous pseudolymphoma. Ann Pathol 28:146–149PubMedCrossRefGoogle Scholar
  12. 12.
    Elston DM, Bergfeld WF, McMahon JT (1993) Aluminum tattoo: a phenomenon that can resemble parasitized histiocytes. J Cutan Pathol 20(4):326–329PubMedCrossRefGoogle Scholar
  13. 13.
    Fawcett HA, Smith NP (1984) Injection-site granuloma due to aluminum. Arch Dermatol 120:1318–1322PubMedCrossRefGoogle Scholar
  14. 14.
    Fawcett HA (1985) Persistent vaccination granuloma due to aluminium hypersensitivity. Brit Jour Dermatol 113:101–102CrossRefGoogle Scholar
  15. 15.
    Frederiksen MS, Tofte H (2004) Immunisation with aluminium-containing vaccine of a child with itching nodule following previous vaccination. Vaccine 23:1–2PubMedCrossRefGoogle Scholar
  16. 16.
    Garg S, Loghdey S, Gawkrodger DJ (2010) Allergic contact dermatitis from aluminium in deodorants. Contact Dermatitis 62:57–58PubMedCrossRefGoogle Scholar
  17. 17.
    Hutteroth TH, Quast U (1990) Aluminum hydroxide granuloma following hepatitis B vaccination. Dtsch Med Wochenschr 115:476PubMedGoogle Scholar
  18. 18.
    Jefferson T, Rudin M, Di Pietrantonj C (2004) Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence. Lancet Infect Dis 4:84–90PubMedCrossRefGoogle Scholar
  19. 19.
    Kaaber K, Nielsen AO, Veien NK (1992) Vaccination granulomas and aluminium allergy: course and prognostic factors. Contact Dermatitis 26:304–306PubMedCrossRefGoogle Scholar
  20. 20.
    Kohl KS, Walop W, Gidudu J et al (2007) Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 25(31):5839–5857PubMedCrossRefGoogle Scholar
  21. 21.
    Lafaye S, Authier FJ, Fraitag S et al (2004) Granuloma with lymphocytic hyperplasia following vaccination: 10 cases. Presence of aluminium in the biopsies. Ann Dermatol Venereol 8–9:769–772CrossRefGoogle Scholar
  22. 22.
    Lehman HK, Faden HS, Fang YV, Ballow M (2008) A case of recurrent sterile abscesses following vaccination: delayed hypersensitivity to aluminum. J Pediatr 152(1):133–135PubMedCrossRefGoogle Scholar
  23. 23.
    Lopez S, Pelaez A, Navarro LA et al (1994) Aluminium allergy in patients hyposensitized with aluminium-precipitated antigen extracts. Contact Dermatitis 31(1):37–40PubMedCrossRefGoogle Scholar
  24. 24.
    Marsee DK, Williams JM, Velazquez EF (2008) Aluminum granuloma after administration of the quadrivalent human papillomavirus vaccine. Report of a case. Am J Dermatopathol 30:622–624PubMedCrossRefGoogle Scholar
  25. 25.
    Maubec E, Pinquier L, Viguier M et al (2005) Vaccination-induced cutaneous pseudolymphoma. J Am Acad Dermatol 52(4):623–629PubMedCrossRefGoogle Scholar
  26. 26.
    McFadden N, Lyberg T, Hensten-Pettersen A (1989) Aluminum-induced granulomas in a tattoo. J Am Acad Dermatol 20:903–908PubMedCrossRefGoogle Scholar
  27. 27.
    Miliauskas JR, Mukherjee T, Dixon B (1993) Postimmunization (vaccination) injection-site reactions. A report of four cases and review of the literature. Am J Surg Pathol 17:516–524PubMedCrossRefGoogle Scholar
  28. 28.
    Netterlid E, Hindsén M, Björk J et al (2009) There is an association between contact allergy to aluminium and persistent subcutaneous nodules in children undergoing hyposensitization therapy. Contact Dermatitis 60:41–49PubMedCrossRefGoogle Scholar
  29. 29.
    Nielsen AO, Kaaber K, Veien NK (1992) Aluminum allergy caused by DTP vaccine. Ugeskr Laeger 154(27):1900–1901PubMedGoogle Scholar
  30. 30.
    Pembroke AC, Marten RH (1979) Unusual cutaneous reactions following diphtheria and tetanus immunization. Clin Exp Dermatol 4:345–348PubMedCrossRefGoogle Scholar
  31. 31.
    Rothstein E, Kohl KS, Ball L et al (2004) Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 22(5–6):575–585PubMedCrossRefGoogle Scholar
  32. 32.
    Schwarze HP, Giordano-Labadie F, Loche F, Gorguet MB, Bazex J (2000) Delayed-hypersensitivity granulomatous reaction induced by blepharopigmentation with aluminum-silicate. J Am Acad Dermatol 42:888–891PubMedCrossRefGoogle Scholar
  33. 33.
    Skowron F, Grezard P, Berard F, Balme B, Perrot H (1998) Persistent nodules at sites of hepatitis B vaccination due to aluminium sensitization. Contact Dermatitis 39:135–136PubMedCrossRefGoogle Scholar
  34. 34.
    Slater DN, Underwood JC, Durrant TE, Gray T, Hopper JP (1982) Aluminium hydroxide granulomas: light and electron microscopic studies and X-ray microanalysis. Br J Dermatol 107:103–108PubMedCrossRefGoogle Scholar
  35. 35.
    Stringfellow HF, Howat AJ (1994) Postimmunization (vaccination) injection-site reactions. Am J Surg Pathol 18:1179–1180PubMedCrossRefGoogle Scholar
  36. 36.
    Veien NK, Hattel T, Justesen O, Norholm A (1986) Aluminium allergy. Contact Dermat 15:295–297CrossRefGoogle Scholar
  37. 37.
    Wahlberg JE (1991) Patch testing. In: Rycroft RJG, Menné T, Frosch PJ, Benezra C (eds) Textbook of contact dermatitis. Springer, Berlin, pp 241–264Google Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.The Research and Development Unit in Local Health Care, County of ÖstergötlandLinköpingSweden
  2. 2.Department of PaediatricsSahlgrenska University Hospital-EastGothenburgSweden

Personalised recommendations